Characterization of chondrocyte scaffold carriers for cell-based gene therapy in articular cartilage repair

Journal of Biomedical Materials Research - Part A

Volumn 101, Issue 12, 2013, Pages 3542-3550

  Shui, Wei ^a   Yin, Liangjun ^a   Luo, Jeffrey ^b   Li, Ruidong ^a   Zhang, Wenwen ^a   Zhang, Jiye ^a   Huang, Wei ^a   Hu, Ning ^a   Liang, Xi ^a   Deng, Zhong Liang ^a   Hu, Zhenming ^a   Shi, Lewis L ^b   Luu, Hue H ^b   Haydon, Rex C ^b   He, Tong Chuan ^a   Ho, Sherwin H ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

articular cartilage; autologous chondrocyte implantation; chondrocyte; ex vivo gene therapy; open cell poly lactic acid (OPLA); scaffold carrier

Indexed keywords

ARTICULAR CARTILAGES; AUTOLOGOUS CHONDROCYTE IMPLANTATIONS; CHONDROCYTES; EX-VIVO; POLY LACTIC ACID;

BODY FLUIDS; CARTILAGE; CELLS; CYTOLOGY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE THERAPY; REPAIR;

SCAFFOLDS (BIOLOGY);

ALCIAN BLUE; COLLAGEN SPONGE; FIBRIN GLUE; HYALURONIC ACID; LUCIFERASE; POLYLACTIC ACID; TISSUE SCAFFOLD;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE MATRIX; CELL BASED GENE THERAPY; CELL ISOLATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; NONHUMAN; RABBIT; TRANSGENE;

ARTICULAR CARTILAGE; AUTOLOGOUS CHONDROCYTE IMPLANTATION; CHONDROCYTE; EX VIVO GENE THERAPY; OPEN-CELL POLY LACTIC ACID (OPLA); SCAFFOLD CARRIER;

ADENOVIRIDAE; ANIMALS; CARTILAGE, ARTICULAR; CELL SEPARATION; CELL SURVIVAL; CHONDROCYTES; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HEK293 CELLS; HUMANS; LACTIC ACID; MALE; POLYMERS; RABBITS; RECOMBINATION, GENETIC; TISSUE SCAFFOLDS; TRANSGENES; WOUND HEALING;

EID: 84886657691     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34661     Document Type: Article

References (38)

1. Chen FS, Frenkel SR, Di Cesare PE,. Repair of articular cartilage defects. II. Treatment options. Am J Orthop 1999; 28: 88-96.
2. Martinek V, Fu FH, Lee CW, Huard J,. Treatment of osteochondral injuries. Genetic engineering. Clin Sports Med 2001; 20: 403-416, viii.
3. Green WT Jr., Behavior of articular chondrocytes in cell culture. Clin Orthop 1971; 75: 248-260.
4. von der Mark K, Gauss V, von der Mark H, Muller P,. Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature 1977; 267: 531-532.
5. Schnabel M, Marlovits S, Eckhoff G, Fichtel I, Gotzen L, Vecsei V, Schlegel J,. Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture. Osteoarthritis Cartilage 2002; 10: 62-70.
6. Shapiro F, Koide S, Glimcher MJ,. Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Joint Surg Am 1993; 75: 532-553.
7. Buckwalter JA, Mow VC, Ratcliffe A,. Restoration of injured or degenerated articular cartilage. J Am Acad Orthop Surg 1994; 2: 192-201.
8. Girotto D, Urbani S, Brun P, Renier D, Barbucci R, Abatangelo G,. Tissue-specific gene expression in chondrocytes grown on three-dimensional hyaluronic acid scaffolds. Biomaterials 2003; 24: 3265-3275.
9. Grande DA, Halberstadt C, Naughton G, Schwartz R, Manji R,. Evaluation of matrix scaffolds for tissue engineering of articular cartilage grafts. J Biomed Mater Res 1997; 34: 211-220.
10. Lee CR, Grodzinsky AJ, Hsu HP, Spector M,. Effects of a cultured autologous chondrocyte-seeded type II collagen scaffold on the healing of a chondral defect in a canine model. J Orthop Res 2003; 21: 272-281.
11. Grigolo B, Lisignoli G, Piacentini A, Fiorini M, Gobbi P, Mazzotti G, Duca M, Pavesio A, Facchini A,. Evidence for redifferentiation of human chondrocytes grown on a hyaluronan-based biomaterial (HYAff 11): Molecular, immunohistochemical and ultrastructural analysis. Biomaterials 2002; 23: 1187-1195.
12. Pavesio A, Abatangelo G, Borrione A, Brocchetta D, Hollander AP, Kon E, Torasso F, Zanasi S, Marcacci M,. Hyaluronan-based scaffolds (Hyalograft C) in the treatment of knee cartilage defects: Preliminary clinical findings. Novartis Found Symp 2003;249:203-217; discussion 229-233, 234-238, 239-241.
13. Brittberg M, Sjogren-Jansson E, Lindahl A, Peterson L,. Influence of fibrin sealant (Tisseel) on osteochondral defect repair in the rabbit knee. Biomaterials 1997; 18: 235-242.
14. Sellers RS, Peluso D, Morris EA,. The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage. J Bone Joint Surg Am 1997; 79: 1452-1463.
15. Peterson L, Minas T, Brittberg M, Nilsson A, Sjogren-Jansson E, Lindahl A,. Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop 2000; 374: 212-234.
16. Brittberg M, Tallheden T, Sjogren-Jansson B, Lindahl A, Peterson L,. Autologous chondrocytes used for articular cartilage repair: An update. Clin Orthop 2001 (391 Suppl): S337-S348.
17. Yildirim S, Akan M, Akoz T,. The use of fibrin adhesive in ear reconstruction with autogenous rib cartilage. Plast Reconstr Surg 2002; 109: 701-705.
18. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B,. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509-2514.
19. Jiang W, Zhou L, Breyer B, Feng T, Cheng H, Haydon R, Ishikawa A, He TC,. Tetracycline-regulated gene expression mediated by a novel chimeric repressor that recruits histone deacetylases in mammalian cells. J Biol Chem 2001; 276: 45168-45174.
20. Zhou L, An N, Haydon RC, Zhou Q, Cheng H, Peng Y, Jiang W, Luu HH, Vanichakarn P, Szatkowski JP, Park JY, Breyer B, He TC,. Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity. Cancer Lett 2003; 193: 161-170.
21. Breyer B, Jiang W, Cheng H, Zhou L, Paul R, Feng T, He TC,. Adenoviral vector-mediated gene transfer for human gene therapy. Curr Gene Ther 2001; 1: 149-162.
22. Hidaka C, Goodrich LR, Chen CT, Warren RF, Crystal RG, Nixon AJ,. Acceleration of cartilage repair by genetically modified chondrocytes over expressing bone morphogenetic protein-7. J Orthop Res 2003; 21: 573-583.
23. Dinser R, Kreppel F, Zaucke F, Blank C, Paulsson M, Kochanek S, Maurer P,. Comparison of long-term transgene expression after non-viral and adenoviral gene transfer into primary articular chondrocytes. Histochem Cell Biol 2001; 116: 69-77.
24. Viggeswarapu M, Boden SD, Liu Y, Hair GA, Louis-Ugbo J, Murakami H, Kim HS, Mayr MT, Hutton WC, Titus L,. Adenoviral delivery of LIM mineralization protein-1 induces new-bone formation in vitro and in vivo. J Bone Joint Surg Am 2001; 83A: 364-376.
25. Peterson L, Brittberg M, Kiviranta I, Akerlund EL, Lindahl A,. Autologous chondrocyte transplantation. Biomechanics and long-term durability. Am J Sports Med 2002; 30: 2-12.
26. Ishimura M, Ohgushi H, Habata T, Tamai S, Fujisawa Y,. Arthroscopic meniscal repair using fibrin glue. I. Experimental study. Arthroscopy 1997; 13: 551-557.
27. van Trommel MF, Simonian PT, Potter HG, Wickiewicz TL,. Arthroscopic meniscal repair with fibrin clot of complete radial tears of the lateral meniscus in the avascular zone. Arthroscopy 1998; 14: 360-365.
28. van Susante JL, Buma P, Schuman L, Homminga GN, van den Berg WB, Veth RP,. Resurfacing potential of heterologous chondrocytes suspended in fibrin glue in large full-thickness defects of femoral articular cartilage: An experimental study in the goat. Biomaterials 1999; 20: 1167-1175.
29. Gruber HE, Ingram JA, Leslie K, Norton HJ, Hanley EN Jr., Cell shape and gene expression in human intervertebral disc cells: In vitro tissue engineering studies. Biotech Histochem 2003; 78: 109-117.
30. Nehrer S, Breinan HA, Ramappa A, Shortkroff S, Young G, Minas T, Sledge CB, Yannas IV, Spector M,. Canine chondrocytes seeded in type I and type II collagen implants investigated in vitro. J Biomed Mater Res 1997; 38: 95-104.
31. Pieper JS, van der Kraan PM, Hafmans T, Kamp J, Buma P, van Susante JL, van den Berg WB, Veerkamp JH, van Kuppevelt TH,. Crosslinked type II collagen matrices: Preparation, characterization, and potential for cartilage engineering. Biomaterials 2002; 23: 3183-3192.
32. Altman RD, Moskowitz R,. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: A randomized clinical trial. Hyalgan Study Group. J Rheumatol 1998; 25: 2203-2212.
33. Moreland LW,. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: Mechanisms of action. Arthritis Res Ther 2003; 5: 54-67.
34. Hollinger JO,. Preliminary report on the osteogenic potential of a biodegradable copolymer of polyactide (PLA) and polyglycolide (PGA). J Biomed Mater Res 1983; 17: 71-82.
35. Nelson JF, Stanford HG, Cutright DE,. Evaluation and comparisons of biodegradable substances as osteogenic agents. Oral Surg Oral Med Oral Pathol 1977; 43: 836-843.
36. Thordarson DB, Samuelson M, Shepherd LE, Merkle PF, Lee J,. Bioabsorbable versus stainless steel screw fixation of the syndesmosis in pronation-lateral rotation ankle fractures: A prospective randomized trial. Foot Ankle Int 2001; 22: 335-338.
37. Chu CR, Monosov AZ, Amiel D,. In situ assessment of cell viability within biodegradable polylactic acid polymer matrices. Biomaterials 1995; 16: 1381-1384.
38. Chu CR, Dounchis JS, Yoshioka M, Sah RL, Coutts RD, Amiel D,. Osteochondral repair using perichondrial cells. A 1-year study in rabbits. Clin Orthop 1997; 340: 220-229.